Alliance Pharmaceutical Corp. Clinical Study Approved To Start In France
Alliance Pharmaceutical Corp. (OTC Bulletin Board: ALLP) today announces the approval from the French Competent Authority to allow the start of the Phase 2 clinical trial for Oxygent(TM) (perfluorochemical [PFC] emulsion) to prevent post-op ileus resulting from hypoxia during major surgery.
Democratic, Republican Lawmakers Prepare Proposals That Would Expand State SCHIP Programs In 2007
Cadence Pharmaceuticals Initiates Pivotal Phase III Clinical Trial Evaluating Intravenous Acetaminophen For Post-Operative Acute Pain
Perrigo Announces Issue Of Approvable Letter By FDA For Dexcel's OTC Omeprazole
ZymoGenetics Submits Biologics License Application To The FDA For RhThrombin As An Aid To Controlling Bleeding During Surgery
Outbreak Of PVL-positive Community-associated MRSA, UK
Incoming House Speaker Pelosi Said Democrats Will Push Legislation That Would Mandate Government Price Negotiations For Medicare Prescription Drugs
Number Of Direct-to-Consumer Prescription Drug Advertisements Reviewed By FDA Has Decreased, GAO Report Finds
Sen. Wyden To Propose Plan That Would Provide Universal Health Care Coverage To All U.S. Residents Without Increasing Costs
Institute For Healthcare Improvement Releases Guidelines To Prevent Five Million Injuries In Hospitals
88 Percent Sensitivity For Colon Cancer Reported Using Non-Invasive Screening Test
Wrongful-Death Lawsuit Filed Against Ortho Evra Manufacturer Ortho-McNeil
Holiday Health/Safety Tips
Got The Holiday Blues? Mental Health Expert Offers Tips For A Happier Holiday Season
No comments:
Post a Comment